Evidence map›Paper›PMID 40573211›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Design and Synthesis of Pyridine-Based Pyrrolo[2,3-

Srinivasulu Cherukupalli, Carsten Degenhart, Peter Habenberger, Anke Unger, Jan Eickhoff, Bård Helge Hoff, Eirik Sundby

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Srinivasulu CherukupalliDepartment of Chemistry, Norwegian University of Science and Technology (NTNU), Høgskoleringen 5, NO-7491 Trondheim, Norway.ORCID 0000-0002-7814-0965
Carsten DegenhartLead Discovery Center GmbH (LDC), Otto-Hahn-Strasse 15, 44227 Dortmund, Germany.
Peter HabenbergerLead Discovery Center GmbH (LDC), Otto-Hahn-Strasse 15, 44227 Dortmund, Germany.ORCID 0000-0002-1251-264X
Anke UngerLead Discovery Center GmbH (LDC), Otto-Hahn-Strasse 15, 44227 Dortmund, Germany.ORCID 0000-0003-1288-3763
Jan EickhoffLead Discovery Center GmbH (LDC), Otto-Hahn-Strasse 15, 44227 Dortmund, Germany.ORCID 0000-0002-5537-438X
Bård Helge HoffDepartment of Chemistry, Norwegian University of Science and Technology (NTNU), Høgskoleringen 5, NO-7491 Trondheim, Norway.ORCID 0000-0001-7859-7810
Eirik SundbyDepartment of Material Science, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.

Funding

Trond Mohn Foundation TMS2019TMT07
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CSF1R inhibitorsmolecular hybridizationPexidartinibpyridinepyrrolo[2,3-d]pyrimidinescaffold hopping

Identifiers

PMID40573211
PMCPMC12196264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.